Drug intelligence / Profile preview

aceclidine

Development stage
Approved
Lead developer
LENZ Therapeutics
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Aceclidine is a direct-acting cholinergic small molecule used as an ophthalmic miotic. It functions primarily as a muscarinic receptor agonist on the iris sphincter and ciliary muscle, producing pupillary constriction that can improve near vision through a pinhole effect in presbyopia. Historically it has also been studied as an antiglaucoma miotic and was noted in older literature to induce less accommodative spasm than pilocarpine in some patients. More recently, LENZ Therapeutics developed aceclidine ophthalmic solution 1.44% as the monotherapy product LNZ100, which was commercialized in the United States as VIZZ for presbyopia; the same active ingredient has also been studied in combination with brimonidine as LNZ101 for presbyopia.

Brand names
VIZZ
Other names
aceclidine
02

Targets

M1 (Muscarinic acetylcholine receptor M1)CHRM4 (M4)CHRM3 (M3)CHRM5 (M5)CHRM2 (M2)

Beyond the preview

Go deeper on aceclidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aceclidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call